FE 999302

DRUG2 trials

Sponsors

Ferring Pharmaceuticals

Conditions

Infertility

Phase 1

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

TerminatedNCT06511791

Ferring PharmaceuticalsInfertility

Start: 2024-07-15End: 2025-10-16Updated: 2026-03-30

Phase 2

Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation

WithdrawnNCT05571111

Ferring PharmaceuticalsInfertility

Start: 2022-10-04End: 2024-06-25Updated: 2023-01-09